Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy

Recruiting Phase 4 Interventional Study
Anesthesia, Local
Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
90 (estimated)
Sponsor
Matias Vested · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of this study is to determine the effect of PENG blockade on postoperative pain after either ropivacaine 5 mg/mL or saline (placebo) in patients undergoing PAO. The hypothesis of this study is that PENG block with ropivacaine reduces postoperative pain compared to placebo (saline).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients ≥ 18 years old 2. Informed consent 3. Scheduled for periacetabular osteotomy under general anesthesia with intubation 4. American Society of Anesthesiologists (ASA) physical status classification I to III 5. Can read and understand Danish Exclusion Criteria: 1. Kno…
Contacts

Matias Vested

+4535455747

matias.vested@regionh.dk

CONTACT